Tag:
India
Latest Headlines
Latest Headlines
Quanticate looks to India to expand ops, despite national controversy
The move reinforces the CRO's commitment to working in the country, despite controversy surrounding India's clinical and pharma handlings.
Indian gov't probes drug regulator after scathing review
Days after a parliamentary report noted shoddy oversight of approvals, the Indian government has mounted an investigation into the alleged misdeeds. Meanwhile, big names in biopharma have surfaced in the sea of allegations.
Report: Bad lifestyles fuel diagnostics boom in emerging markets
The international research outfit GlobalData sees both factors like unhealthy lifestyles as pushing the in vitro diagnostics markets in some countries to climb by 16% annually, reaching a combined $11.7 billion by 2018.
Indian panel accuses Big Pharma of colluding with regulators
An Indian government report has hit the domestic pharma business like a whirlwind--and sucked Big Pharma into the fury.
Subpar clinical trials probed in India's review of regulation
Indian lawmakers and patient advocates charge that their regulator rubber-stamped drugs to be sold in the county without required clinical trials.
CMO outsourcing in Asia expected to reach $60B by 2018
A study conducted by GBI Research predicts that CMO outsourcing in Asia will generate $60 billion in revenues by 2018.
Bayer slams Indian government, Cipla on Nexavar copies
Since the Indian government yanked its exclusivity on the cancer drug, the German company is fighting back.
Abbott, Syngene to open first R&D nutrition center in India
The Abbott Nutrition R&D Center is an effort between Abbott and Syngene to develop nutritional products, while expanding Abbott's nutrition portfolio at the same time.
With upgrades, India to reopen 3 vaccine plants
An Indian company known for making condoms has completed upgrades on a vaccine plant there and is nearing completion on two others.
UPDATED: ACRO India speaks out against report of video recording clinical trials
ACRO India is casting doubt over a Pharmabiz article that claims efforts to video record clinical trials in the country was sprung by the umbrella organization, but in its response manages not to confirm or deny any involvement.
